دورية أكاديمية

Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

التفاصيل البيبلوغرافية
العنوان: Short and Long-Term Prognostic Significance of Galectin-3 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
المؤلفون: Köktürk, Uğur, Püşüroğlu, Hamdi, Somuncu, Mustafa Umut, Akgül, Özgür, Uygur, Begüm, Özyılmaz, Sinem, Işıksaçan, Nilgün, Sürgit, Özgür, Yıldırım, Aydın
المصدر: Angiology; Oct2023, Vol. 74 Issue 9, p889-896, 8p
مصطلحات موضوعية: MORTALITY risk factors, CARDIOVASCULAR disease related mortality, PROTEINS, BIOMARKERS, PATIENT aftercare, PERCUTANEOUS coronary intervention, VENTRICULAR ejection fraction, MULTIVARIATE analysis, PATIENTS, PATIENT readmissions, ST elevation myocardial infarction, HOSPITAL admission & discharge, TREATMENT effectiveness, RISK assessment, DESCRIPTIVE statistics, HEART failure, PROPORTIONAL hazards models
مستخلص: This study evaluated the short and long-term prognostic value of galectin-3 in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI). Patients (n = 143) were admitted with STEMI and followed up for 2 years. The study population was divided into high and low galectin-3 groups based on the admission median value of serum galectin-3. Primary clinical outcomes consisted of cardiovascular (CV) mortality, non-fatal reinfarction, stroke, and target vessel revascularization (TVR). CV events were recorded in hospital and at 1 and 2 years. The primary clinical outcomes (in-hospital, 1 year and 2 year) were significantly higher in the high galectin-3 group. (P =.008, P =.004, P =.002, respectively). High galectin-3 levels were also associated with heart failure development and re-hospitalization at both 1 year (P =.029, P =.009, respectively) and 2 years (P =.019, P =.036, respectively). According to Cox multivariate analysis, left ventricular ejection fraction (LVEF) was an independent predictor of 2-year cardiovascular mortality (P =.009), whereas galectin-3 was not (P =.291). Although high galectin-3 levels were not independent predictors of long-term CV mortality in patients with acute STEMI who underwent primary PCI, it was associated with short-term and long-term development of adverse CV events, heart failure, and re-hospitalization. [ABSTRACT FROM AUTHOR]
Copyright of Angiology is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00033197
DOI:10.1177/00033197221149846